Applied DNA Sciences Inc (APDN)
0.18
0.00 (0.00%)
USD |
NASDAQ |
Nov 05, 10:17
Applied DNA Sciences Enterprise Value: -8.715M for Nov. 4, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
November 04, 2024 | -8.715M |
November 01, 2024 | -8.578M |
October 31, 2024 | -8.730M |
October 30, 2024 | -8.658M |
October 29, 2024 | -7.334M |
October 28, 2024 | -7.435M |
October 25, 2024 | -7.413M |
October 24, 2024 | -7.407M |
October 23, 2024 | -7.014M |
October 22, 2024 | -7.108M |
October 21, 2024 | -6.737M |
October 18, 2024 | -7.266M |
October 17, 2024 | -7.335M |
October 16, 2024 | -7.366M |
October 15, 2024 | -7.591M |
October 14, 2024 | -7.510M |
October 11, 2024 | -7.355M |
October 10, 2024 | -7.294M |
October 09, 2024 | -6.995M |
October 08, 2024 | -6.800M |
October 07, 2024 | -6.732M |
October 04, 2024 | -6.794M |
October 03, 2024 | -6.794M |
October 02, 2024 | -7.098M |
October 01, 2024 | -7.056M |
Date | Value |
---|---|
September 30, 2024 | -3.908M |
September 27, 2024 | -1.038M |
September 26, 2024 | -0.1973M |
September 25, 2024 | 0.0087M |
September 24, 2024 | -0.7637M |
September 23, 2024 | 1.039M |
September 20, 2024 | 2.223M |
September 19, 2024 | 1.863M |
September 18, 2024 | 2.996M |
September 17, 2024 | 3.510M |
September 16, 2024 | 3.098M |
September 13, 2024 | 3.510M |
September 12, 2024 | 4.849M |
September 11, 2024 | 4.952M |
September 10, 2024 | 2.584M |
September 09, 2024 | 3.716M |
September 06, 2024 | 4.334M |
September 05, 2024 | 2.893M |
September 04, 2024 | 1.760M |
September 03, 2024 | 5.055M |
August 30, 2024 | 9.072M |
August 29, 2024 | 12.16M |
August 28, 2024 | 14.32M |
August 27, 2024 | 14.02M |
August 26, 2024 | 12.06M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-8.730M
Minimum
Oct 31 2024
90.55M
Maximum
Feb 11 2021
17.55M
Average
9.072M
Median
Aug 30 2024
Enterprise Value Benchmarks
Fonar Corp | 28.39M |
XWELL Inc | -0.7802M |
ProPhase Labs Inc | 53.59M |
Veracyte Inc | 2.454B |
OncoCyte Corp | 39.57M |
Enterprise Value Related Metrics
Net Income (Quarterly) | 1.880M |
Revenue (Quarterly) | 0.7975M |
Total Expenses (Quarterly) | 4.144M |
EPS Diluted (Quarterly) | 0.47 |
Gross Profit Margin (Quarterly) | 30.75% |
Earnings Yield | -6.66K% |
Normalized Earnings Yield | -9373.77 |